SCHEMBL20878398

SCHEMBL20878398

CC(C)(C)C(=O)SCCOP(=O)(OCCSC(=O)C(C)(C)C)OC[C@@H](OC#N)[C@@H](O)Cc1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22646503 0.89 RIPK1 (0.31) —
SCHEMBL20762554 0.86 RIPK1 (0.31) —
SCHEMBL20078700 0.82 RIPK1 (0.32) —
SCHEMBL21120509 0.80 RIPK1 (0.32) —
SCHEMBL24119267 0.80 RIPK1 (0.32) —
SCHEMBL25511390 0.80 RIPK1 (0.33) —
SCHEMBL20762604 0.79 RIPK1 (0.31) —
SCHEMBL22646487 0.77 RIPK1 (0.32) —
SCHEMBL24942295 0.72 RIPK1 (0.34) —
SCHEMBL22096273 0.72 CA12 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10251898-B2 Methods for treating Filoviridae virus infections GILEAD SCIENCES, INC. (US) 2019-04-09 — — US disclosed
Send feedback